Skip to main content

This Genomics ETF Has Some Coronavirus Vaccine Leverage

The race is on to find a cure for the deadly coronavirus and that competition could benefit some ETFs, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG includes companies that merge healthcare with technology and capitalize on the revolution in genomic sequencing. These...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.